IsoPlexis People in the News: New Appointments at NeoGenomics, Mainz Biomed, IsoPlexis, More Isoplexis Q3 Revenues Grow 28 Percent The single-cell analysis company, which went public in October, posted revenues of $4.2 million, up from 3.3 million in the year-ago period. IsoPlexis Using IPO Funds to Support Move Into Transcriptomics, Metabolomics Premium The firm is expanding beyond single-cell proteomics with new data types that could help it move into research areas outside its traditional immune profiling focus. IsoPlexis Raises $125M in IPO The company offered 8.3 million shares at $15 per share and begins trading today on the Nasdaq under the ticker symbol "ISO." People in the News: New Appointments at IsoPlexis, Centogene, Progenity, More May 28, 2021 In Brief This Week: Bio-Rad, 10x Genomics, IsoPlexis, 23andMe, PerkinElmer, LifeBit Biotech, More May 18, 2021 IsoPlexis Inks Swiss Distribution Deal With Bucher Biotech May 14, 2021 People in the News: New Appointments at Berkeley Lights, Castle Bio, IsoPlexis, More Jan 7, 2021 IsoPlexis Raises $135M in Series D Financing Round Nov 18, 2020 IsoPlexis Targets New Market Segments With Cheaper, More Flexible Single-Cell Proteomic Systems Premium Nov 17, 2020 New NGS-Based Tissue Analysis Method Offers Spatial Detail on Transcriptome, Proteins Premium Oct 8, 2020 IsoPlexis Partnering With Yale on Assays for Assessing Immune Response to COVID-19 Aug 25, 2020 IsoPlexis, Medquest Ink Distribution Deal for Singapore, Malaysia Aug 14, 2020 IsoPlexis Partnering With Columbia to Study Immune Response to SARS-CoV-2 Jul 28, 2020 IsoPlexis Partners With Neoline Technology to Sell Products in China Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.